Back

Novel risk model for predicting acute adverse drug reactions following cardiac catheterization from TRUST study (the safety and tolerability of ultravist in patients undergoing cardiac catheterization

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2 Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Yong Liu

Guangdong General Hospital Guangdong Cardiovascular Institute, Guangzhou (China)

9 More presentations in this session

Presentation thumbnail
Doctor F. Fioravanti (Milan, IT)
Abstract
Presentation thumbnail
Doctor I. El-Battrawy (Bochum, DE)
Abstract
Presentation thumbnail
Doctor S. Kasturi (Hyderabad, IN)
Abstract Slides
Presentation thumbnail
Ms E. Hartman (Rotterdam, NL)
Abstract
Presentation thumbnail
Mr J. Smit (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources